Why Choose One Pharmacy For Your Complete Wegovy Journey?
Complete Wegovy 1.7mg vs Mounjaro Dose Comparison
Understanding Wegovy 1.7 equivalent to Mounjaro requires examining the full treatment spectrum. Wegovy follows a structured five-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17. Mounjaro similarly escalates but uses different increments: 2.5mg, 5mg, 7.5mg, 10mg, and 15mg maximum. Your current 1.7mg position represents the penultimate step before maintenance, where treatment results typically accelerate most dramatically.
Both medications require prescription oversight and clinical assessment, yet their mechanisms differ significantly. Wegovy's semaglutide targets GLP-1 receptors exclusively, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 pathways. EverydayMeds stocks complete ranges for both treatments, allowing your prescriber to determine the most suitable option based on your individual response patterns and clinical profile.
Wegovy All Doses Pricing and Value Framework
EverydayMeds maintains transparent pricing across the complete Wegovy range: 0.25mg starter at £79.99, 0.5mg at £94.99, 1mg at £99.99, your current 1.7mg at £139.99, and 2.4mg maintenance at £209.99. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for continued value. Bundle options streamline your transition—our Elevate Duo combines 1.7mg and 2.4mg for £369.99, providing seamless progression to maintenance dosing.
For patients requiring extended periods at current doses, our Consistency 1.7mg bundle provides two pens for £309.99. This approach suits individuals experiencing optimal results at 1.7mg who may benefit from extended stabilisation before advancing. Your prescriber can adjust escalation timing based on tolerance and efficacy markers, ensuring treatment remains both effective and comfortable throughout your journey.
Clinical Evidence Comparing Wegovy 1.7mg Equivalent to Mounjaro
The STEP clinical trial programme demonstrated Wegovy's efficacy across its dose range, with patients achieving approximately 15% average weight reduction at 68 weeks when combined with lifestyle modifications (Wilding et al., NEJM, 2021). The 1.7mg dose represents a critical escalation point where therapeutic benefits typically intensify before reaching full maintenance levels.
Mounjaro's SURMOUNT trials showed comparable efficacy using its tirzepatide mechanism, though direct head-to-head comparisons remain limited due to different trial designs and populations. Both treatments require ongoing commitment alongside reduced-calorie diet and increased physical activity to maintain optimal outcomes throughout the treatment period.
How Wegovy 1.7mg Functions in Your System
Wegovy operates as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate appetite and satiety. At 1.7mg dosing, semaglutide binds to GLP-1 receptors in the hypothalamus, reducing hunger signals whilst promoting feelings of fullness after smaller meals. This mechanism may also influence food cravings by affecting reward pathways in the brain's appetite centres. The once-weekly injection schedule maintains consistent therapeutic levels, supporting sustained appetite regulation throughout each seven-day period. Your current 1.7mg strength provides near-maximum receptor activation, preparing your system for full maintenance dosing at 2.4mg.
Streamlined Ordering Process for All Wegovy Doses
EverydayMeds simplifies access to your complete Wegovy treatment through our three-minute online clinical assessment covering medical history, current medications, and weight management goals. Our prescribers review applications within three working days (or 24 hours with express service), ensuring thorough safety evaluation before approval. Once authorised, next-day delivery maintains cold-chain integrity using temperature-controlled packaging suitable for the prescription-only medicine requirements. This process applies consistently whether ordering individual 1.7mg pens or bundle combinations, maintaining the same clinical standards throughout your treatment journey. Our GPhC registration #9012878 ensures full regulatory compliance for all Wegovy strengths.
Storage and Practical Advantages Over Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, maintaining stability for six weeks at room temperature below 30°C once removed from refrigeration. Mounjaro requires refrigeration return within 21 days, limiting travel and lifestyle flexibility. The FlexTouch pen design provides precise dose delivery with audible confirmation clicks, whilst the clear medication window allows visual inspection before each injection. Pre-filled pens eliminate measurement errors common with vial-based systems, and the thin 32-gauge needle minimises injection discomfort. These practical advantages become particularly relevant during the 1.7mg phase when treatment adherence directly impacts progression to maintenance dosing success.
Complete Dose Range Strategy for Wegovy vs Mounjaro Decisions
Patients comparing Wegovy 1.7 equivalent to Mounjaro benefit from understanding complete treatment pathways rather than individual dose comparisons. EverydayMeds maintains every Wegovy strength, allowing seamless progression without pharmacy transfers that might disrupt treatment continuity. Your prescriber can adjust escalation timing based on individual tolerance patterns, potentially extending 1.7mg duration or accelerating to 2.4mg maintenance as clinically appropriate.
This comprehensive approach eliminates supply chain concerns that plague patients using multiple pharmacies throughout their journey. Bundle options like our Progress Trio (1mg, 1.7mg, 2.4mg for £499.99) provide three-month security whilst maintaining cost effectiveness compared to individual ordering. Both Wegovy and Mounjaro remain available from EverydayMeds, allowing your prescriber to help determine which treatment aligns best with your clinical profile and lifestyle requirements.
Next Steps for Your Wegovy 1.7mg Treatment
Your current 1.7mg position opens multiple pathway options depending on individual response and clinical assessment. Consider our Elevate Duo bundle combining current 1.7mg with 2.4mg maintenance for seamless transition planning. Returning customers should apply code DOSE25 at checkout to maintain optimal pricing throughout their treatment journey. Our clinical team remains available for consultation regarding dose timing, side effect management, and maintenance planning strategies. Visit https://everydaymeds.co.uk/collections/wegovy to access your next supply or explore bundle options that support long-term treatment success. Remember that weight management represents a long-term commitment requiring ongoing clinical oversight and lifestyle modifications alongside your prescribed medication.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
